IncobotulinumtoxinA is effective and well-tolerated in the treatment of glabellar frown lines, horizontal forehead lines, and lateral canthal lines.

A new 55mg prefilled syringe has been cleared to facilitate weight-based dosing for children weighing less than 40kg. The Food and Drug Administration (FDA) has expanded the approval of Skyrizi ® ...

The 3 largest Medicare Advantage insurers turned down requests for post-hospital care at some of the highest rates among major plans.

The US military is again requiring flu shots for new recruits as an outbreak at an Air Force training base spreads.

The FDA has granted Fast Track designation to BM-3103, a novel topical mTOR inhibitor for epidermolysis bullosa simplex currently in phase 2.

Discordance between patient and physician global assessment scores is common in SSc, with each incorporating different factors when assessing.

Topical corticosteroids for the treatment of dermatologic conditions are not associated with an increased risk for incident type 2 diabetes.

Treatment patterns and patient characteristics varied among those with vitiligo based on the proportion of BSA involved and across age groups.

The American College of Physicians released clinical guidance on pharmacologic treatments for weight management in nonpregnant adults with overweight or obesity. HealthDay News — In a new living ...